Total paracentesis in non-alcoholic cirrhotics with massive ascites: mid-term effects on systemic and hepatic haemodynamics and renal function

J Gastroenterol Hepatol. 1994 Nov-Dec;9(6):592-6. doi: 10.1111/j.1440-1746.1994.tb01567.x.

Abstract

Single total paracentesis (4.8-11 L) was performed in 23 patients with hepatitis B surface antigen (HBsAg)-positive cirrhosis and massive ascites and its effects on systemic and hepatic haemodynamics and renal function were examined over 5 days. Severe hypotension occurred in six (26.1%) patients from 6 to 54 h after paracentesis. In the remaining 17 patients, compared to the baseline, there was an increase in the cardiac output (6.1 +/- 0.3 vs 6.7 +/- 0.3 L/min, P < 0.001) and a decrease in right atrial pressure (8.8 +/- 0.8 vs 4.3 +/- 0.7 mmHg, P < 0.001), systemic vascular resistance (1160 +/- 61 vs 976 +/- 50 dyne.s.cm-5, P < 0.001), and wedged hepatic venous pressure 30 min after completion of paracentesis. After 5 days, right atrial pressure, systemic vascular resistance and wedged hepatic venous pressure returned to baseline, while the cardiac output dropped to a level lower than the baseline (5.7 +/- 0.7 L/min, P < 0.05). Hepatic venous pressure gradient had returned to baseline after 5 days. Serial tests of serum creatinine level showed an increase from day 3 (1.34 +/- 0.14 vs 1.04 +/- 0.10 mg/dL, P < 0.05). On day 5, creatinine clearance (55.7 +/- 5.4 vs 41.9 +/- 5.3 mL/min, P < 0.05) and effective renal plasma flow (351 +/- 32 vs 293 +/- 29 mL/min, P < 0.05) were decreased, compared to the baseline. Based on these data, infusion of a volume expander may be necessary for total paracentesis to avoid systemic haemodynamic complications in non-alcoholic cirrhosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ascites / etiology
  • Ascites / therapy*
  • Drainage / methods
  • Female
  • Hemodynamics / physiology*
  • Hepatitis B Surface Antigens / analysis
  • Humans
  • Hypotension / etiology
  • Kidney / physiopathology*
  • Liver Circulation / physiology*
  • Liver Cirrhosis / complications*
  • Liver Cirrhosis / physiopathology
  • Liver Cirrhosis / virology
  • Male
  • Middle Aged
  • Plasma Substitutes / therapeutic use
  • Punctures
  • Time Factors

Substances

  • Hepatitis B Surface Antigens
  • Plasma Substitutes